A syndrome resembling adrenal cortical insufficiency associated with long term busulfan (myleran) therapy.

No abstract is available for this paper.

• Publication year

  1961

• Venue

  Blood

• Publication date

  1961-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD.V18.5.497.497PMID 14461123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interstitial pulmonary fibrosis following busulfan therapy.

  1961cited by this paper
• Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy.

  1961cited by this paper
• Chronic Granulocytic Leukemia in Childhood

  1960cited by this paper
• Effect of Triethylene Thiophosphoramide (ThioTEPA) on Skin Pigmentation in Mice.∗

  1960cited by this paper
• Chromosomes deficiencies induced with Myleran

  1959cited by this paper
• Effect of my-leran and 6-mercaptopurine (6-MP) on the serum level of vitamin B12 in chronic myelocytic leukemia.

  1959cited by this paper
• Metabolic and Chemical Studies of ‘Myleran’: Formation of 3-Hydroxytetrahydrothiophene-1,1-Dioxide In Vivo, and Reactions With Thiols In Vitro

  1959cited by this paper
• Myleran in the treatment of chronic myelogenous leukemia.

  1959cited by this paper
• Acute myeloblastic transformation after busulfan treatment of chronic myelocytic leukemia.

  1959cited by this paper
• The effect of alkylating agents on male rat fertility.

  1959cited by this paper
• COMPARATIVE EFFECTS OF ALKYLATING AGENTS ON CELLULAR MORPHOLOGY

  1958cited by this paper
• THE REACTIONS OF THE “RADIOMIMETIC” ALKYLATING AGENTS WITH MACROMOLECULES IN VITRO

  1958cited by this paper
• BUSULFAN (1,4‐DIMETHANESULFONYLOXYBUTANE, MYLERAN): SUMMARY OF CLINICAL, RESULTS

  1958cited by this paper
• MYLERAN AND TRIETHYLENE MELAMINE IN THE TREATMENT OF CHRONIC GRANULOCYTIC LEUKEMIA

  1958cited by this paper
• IN VITRO REACTIONS OF BIOLOGICAL ALKYLATING AGENTS

  1958cited by this paper
• Treatment of chronic granulocytic leukemia with myleran.

  1957cited by this paper
• Medullary Aplasia in Chronic Myeloid Leukaemia during Busulphan Therapy

  1957cited by this paper
• Myleran Treatment in Chronic Granulocytic Leukaemia

  1957cited by this paper
• Myleran treatment of chronic granulocytic leukemia.

  1956cited by this paper
• Effects of dietary supplements in preventing or augmenting the production of cataracts in rats by 1, 4-dimethanesulfonoxybutane.

  1956cited by this paper
• The use of myleran and similar agents in chronic leukemias.

  1956cited by this paper
• Treatment of chronic granulocytic leukemia with 1, 4-dimethanesulfonyloxybutane (myleran).

  1956cited by this paper
• Myleran in the treatment of chronic granulocytic leukemia.

  1956cited by this paper
• Treatment of chronic granulocytic leukemia with myleran.

  1956cited by this paper
• Effect of myleran treatment on the P32 uptake of leukocytic deoxyribonucleic acid in chronic granulocytic leukemia

  1956cited by this paper
• Myleran therapy in malignant neoplastic disease; use of 1,4-dimethanesulfonyloxbutane with emphasis on chronic granulocytic leukemia.

  1956cited by this paper
• [Effects of myleran in 22 cases of chronic myeloid leukemia].

  1956cited by this paper
• Myleran in Treatment of Chronic Myeloid Leukaemia

  1956cited by this paper
• The use of myleran in the treatment of chronic myelocytic leukemia.

  1955cited by this paper
• Myleran (GT 41) in the treatment of leukaemia.

  1955cited by this paper
• The effect of 1,4‐dimethanesulfonyloxybutane (GT‐41 or myleran) upon leukemia

  1954cited by this paper
• Chemotherapy of leukemia, Hodgkin's disease and related disorders.

  1954cited by this paper
• [Myleran, a new cytostatic drug in leukemias].

  1953cited by this paper
• [The effect of myleran on the germ cells of rats].

  1953cited by this paper
• Biochemistry of melanin formation.

  1950cited by this paper
• Mammalian tyrosinase; the relationship of copper to enzymatic activity.

  1950cited by this paper
• Inhibitory Action of Human Epidermis on Melanin Formation

  1946cited by this paper

• Effect of Gosha-Jinki-Gan on Levels of Specific mRNA Transcripts in Mouse Testes after Busulfan Treatment

  2020cites this paper
• Gosha-Jinki-Gan Recovers Spermatogenesis in Mice with Busulfan-Induced Aspermatogenesis

  2018cites this paper
• Busulfan pretreatment for transplantation of rat spermatogonia differentially affects immune and reproductive systems in male recipient mice

  2015cites this paper
• Disorders of Skin Colour

  2010cites this paper
• Clinical and morphological side-effects of busulfan (Myleran) treatment.

  2009cites this paper
• Alopecia and Cutaneous Complications

  2008cites this paper
• Endocrine sequelae of cancer and cancer treatments

  2007cites this paper
• Chronische myeloische Leukämie (CML)

  2006cites this paper
• Nutritional Consequences of Cancer Chemotherapy and Immunotherapy1

  2006cites this paper
• Klinische Aspekte der Chemotherapie bösartiger Tumoren und maligner Systemerkrankungen

  2004cites this paper
• Chronic myeloid leukemia.

  2004cites this paper
• Enhanced cutaneous radiation effects following high-dose busulfan therapy

  2004cites this paper
• Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy.

  1998cites this paper
• The endocrine effects of nonhormonal antineoplastic therapy.

  1998cites this paper
• Pigmentary diseases.

  1998cites this paper
• Diffuse hyperpigmentation of the skin: a clinicopathologic approach to diagnosis.

  1997cites this paper
• Supravenous hyperpigmentation induced by vinorelbine.

  1994cites this paper
• Busulfan

  1994cites this paper
• Therapy of chronic myelogenous leukemia

  1993cites this paper
• CUTANEOUS HYPERPIGMENTATION CAUSED BY SYSTEMIC DRUGS

  1992cites this paper
• Dermatologic toxicity of chemotherapy.

  1992cites this paper
• Serpentine supravenous hyperpigmentation induced by the nitrosourea fotemustine.

  1992cites this paper
• Pharmacology of agents used in bone marrow transplant conditioning regimens.

  1992cites this paper
• Nail and mucocutaneous hyperpigmentation with azidothymidine therapy.

  1990cites this paper
• Options for the Management of Chronic Myeloid Leukaemia-1990.

  1990cites this paper
• Pigmentary disorders and systemic drug therapy.

  1989cites this paper
• [Cutaneous side effects of antitumor chemotherapy].

  1989cites this paper
• Effects of busulfan on murine spermatogenesis: cytotoxicity, sterility, sperm abnormalities, and dominant lethal mutations.

  1987cites this paper
• Cutaneous side effects of cancer chemotherapy.

  1986cites this paper
• Toxicological review of busulfan (Myleran).

  1986cites this paper
• Preliminary results of high-dose busulfan and cyclophosphamide with syngeneic or autologous bone marrow rescue.

  1984cites this paper
• [Chronic myeloid leukemia treated with busulfan. Clinical characteristics, prognostic factors, effect of treatment and survival in 82 cases].

  1984cites this paper
• A case of pulmonary alveolar proteinosis complicating chronic myelogenous leukemia a peculiar pathologic aspect of busulfan lung?

  1984cites this paper
• [Cutaneous lesions induced by long-term use of hydroxyurea].

  1984cites this paper
• A patient with an isolated ACTH deficiency.

  1984cites this paper
• Cutaneous complications of chemotherapeutic agents.

  1983cites this paper
• Clinical toxicity of chemotherapeutic agents: dermatologic toxicity.

  1982cites this paper
• Immunopathology and Pathogenesis of Cutaneous Lupus Erythematosus

  1981cites this paper
• Continuin medical education Drug- and heavy metal-induced hyperpigmentation

  1981cites this paper
• 5 – OTHER ALKYLATING AGENTS

  1981cites this paper
• Drug- and heavy metal--induced hyperpigmentation.

  1981cites this paper
• Busulfan-induced hemorrhagic cystitis.

  1981cites this paper
• Mucocutaneous reactions to antineoplastic agents

  1980cites this paper
• BUSULFAN HYPERPIGMENTATION: LIGHT AND ELECTRON MICROSCOPIC STUDIES

  1980cites this paper
• "Allopurinol-type" rash due to busulphan.

  1978cites this paper
• Die chronische myeloische Leukämie

  1978cites this paper
• Uneven geographical distribution of 15;17-translocation in acute promyelocytic leukaemia.

  1978cites this paper
• Treatment of chronic granulocytic leukemia with melphalan.

  1978cites this paper
• Komplikationen und supportive Therapie der Leukämien und malignen Non-Hodgkin-Lymphome

  1978cites this paper
• Mucocutaneous side effects of cancer chemotherapy.

  1978cites this paper
• [Chronic myelocytic leukemia in childhood and adolescence].

  1978cites this paper
• VARIED PULMONARY LESIONS WITH INTRAALVEOLAR LARGE LAMELLAR BODIES IN AN AUTOPSY CASE WITH BUSULFAN THERAPY

  1977cites this paper
• Toxicity of Chemotherapeutic Agents

  1977cites this paper
• Defining the endocrine and metabolic aspects of cancer.

  1977cites this paper
• Fatal radiation pneumonia following subclinical busulfin injury.

  1977cites this paper
• [Clinical heterogeneity of Myleran-induced pneumopathy. Apropos of 2 further cases and review of the literature].

  1977cites this paper
• Medications and Their Toxicity

  1977cites this paper
• Nutritional consequences of cancer chemotherapy and immunotherapy.

  1977cites this paper
• Cytotoxic drug-induced lung disease.

  1977cites this paper
• Die chronischen Leukämien des Erwachsenen

  1976cites this paper
• Application of the Basic Principles of Chemotherapy to Human Malignancies

  1976cites this paper
• Pharmacological and pathological responses of the human pulmonary circulation to drugs.

  1976cites this paper
• [Cutaneous side effects of systemic drugs. Part 4 of a synopsis. 6/7. Drugs affecting the central nervous system. C. Drug-induced photosensitivity. D. Drug-induced changes of skin color].

  1976cites this paper
• Non-oncogenic sequelae of cancer chemotherapy.

  1975cites this paper
• Generalized melanoses and nonmelanotic pigmentations of the head and neck

  1975cites this paper
• Busulphan toxicity syndrome caused by chlorambucil.

  1975cites this paper
• [Experiences with radioactive phosphorus therapy in cases of polycythemia vera (author's transl)].

  1975cites this paper
• Chronic myelogenous leukemia. Disseminated intravascular coagulation and chloromas containing sea-blue histiocytes.

  1975cites this paper
• Present status of32P-therapy in management of polycythemia vera

  1975cites this paper
• Mechanism of Action of Methanesulfonates

  1975cites this paper
• Endocardial fibrosis following busulfan treatment.

  1975cites this paper
• Generalized melanoses and nonmelanotic pigmentations of the head and neck.

  1975cites this paper
• [Toxic effects of busulfan (myleran) in the treatment of chronic myeolid leukemia].

  1974cites this paper
• Busulfan lung. Report of two cases and review of the literature.

  1974cites this paper
• Current concepts in chronic myelogenous leukemia.

  1974cites this paper
• DRUG REACTIONS XXIV

  1974cites this paper
• Current concepts in the treatment of chronic myelocytic leukemia.

  1973cites this paper
• Drug induced changes in pigmentation

  1973cites this paper
• Epidermal changes in vitamin B 12 deficiency.

  1973cites this paper
• Clinical dermatology. 2.

  1973cites this paper
• Cancer chemotherapy. I.

  1972cites this paper
• Guide to the use of cancer chemotherapeutic agents.

  1972cites this paper
• Adrenocorticotrophic-hormone deficiency in chronic myelogenous leukemia after treatment.

  1970cites this paper
• Bullous eruption and elevated leukocyte alkaline phosphatase in the course of busulfan-treated chronic granulocytic leukemia.

  1970cites this paper
• Lung Function in Patients Receiving Busulphan

  1970cites this paper
• Leukemia, drugs and ACTH.

  1970cites this paper
• Busulfan-induced pulmonary disease. Report of a case and review of the literature.

  1970cites this paper
• SOME EFFECTS OF ALKYLATING AGENTS ON EPITHELIA IN MAN AND IN AN EXPERIMENTAL SYSTEM IN THE RAT *

  1969cites this paper
• Effects of long-term administration of busulfan. Report of a patient with generalized nuclear abnormalities, carcinoma of vulva, and pulmonary fibrosis.

  1969cites this paper
• Busulphan lung

  1969cites this paper
• Allergy and drug sensitivity of skin.

  1969cites this paper
• Chemotherapy of chronic myelocytic leukemia.

  1969cites this paper
• Interstitial pulmonary fibrosis, atypical epithelial changes and bronchiolar cell carcinoma following busulfan therapy

  1968cites this paper
• Myasthenia gravis in a patient with chronic myeloid leukemia treated by busulfan.

  1968cites this paper
• The skin and antitumor drugs.

  1967cites this paper
• Symposium on immunosuppressive drugs. Late effects of immunosuppressive anticancer drugs.

  1967cites this paper
• "Selective" pituitary insufficiency secondary to busulfan.

  1967cites this paper
• The Skin and Antitumor Drugs: A Special Lecture in Honor of Dr. Charles C. Dennie

  1967cites this paper
• [Clinical aspects of chemotherapy of malignant tumors and malignant systemic diseases].

  1966cites this paper
• Some problems in the management of leukaemia and lymphoma.

  1966cites this paper